Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Simultaneous inhibition of CD73 and IL-6 molecules by siRNA-loaded nanoparticles prevents the growth and spread of cancer
Sima Emadi Allahyari, Farnaz Hajizadeh, Angelina Olegovna Zekiy, et al.
Nanomedicine Nanotechnology Biology and Medicine (2021) Vol. 34, pp. 102384-102384
Closed Access | Times Cited: 18

Showing 18 citing articles:

Simultaneous blockade of the CD73/EGFR axis inhibits tumor growth
Keivan Ardeshiri, Hadi Hassannia, Ghasem Ghalamfarsa, et al.
IUBMB Life (2025) Vol. 77, Iss. 1
Closed Access | Times Cited: 1
Biopolymer-Based Nanomedicine for Cancer Therapy: Opportunities and Challenges
Xixi Wu, Xin Yuan, Hengtong Zhang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 7415-7471
Open Access | Times Cited: 5
Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies
Wenhui Jia, Zhao Huang, Li Zhou, et al.
Drug Resistance Updates (2023) Vol. 70, pp. 100988-100988
Open Access | Times Cited: 13
Gene Therapy with Chitosan Nanoparticles: Modern Formulation Strategies for Enhancing Cancer Cell Transfection
Varvara Antoniou, Elena A. Mourelatou, Eleftheria Galatou, et al.
Pharmaceutics (2024) Vol. 16, Iss. 7, pp. 868-868
Open Access | Times Cited: 4
Delivery of Nucleic Acid Drugs for Tumor Therapy: Opportunities and Challenges
Dandan Sun, Wenjia Tan, Jianan Zhao, et al.
Fundamental Research (2024)
Open Access | Times Cited: 3
Nanoparticles targeting the adenosine pathway for cancer immunotherapy
Kehua Jiang, Jian Wu, Qing Wang, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 24, pp. 5787-5811
Closed Access | Times Cited: 3
RETRACTED: Simultaneous silencing of the A2aR and PD-1 immune checkpoints by siRNA-loaded nanoparticles enhances the immunotherapeutic potential of dendritic cell vaccine in tumor experimental models
Fariba Karoon Kiani, Sepideh Izadi, Ehsan Ansari Dezfouli, et al.
Life Sciences (2021) Vol. 288, pp. 120166-120166
Closed Access | Times Cited: 21
siRNA and targeted delivery systems in breast cancer therapy
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Maliheh Entezari, et al.
Clinical & Translational Oncology (2022) Vol. 25, Iss. 5, pp. 1167-1188
Closed Access | Times Cited: 10
RETRACTED ARTICLE: Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model
Asal Barshidi, Vahid Karpisheh, Fatemeh Karimian Noukabadi, et al.
Pharmaceutical Research (2022) Vol. 39, Iss. 8, pp. 1851-1866
Closed Access | Times Cited: 9
Adenosine: The common target between cancer immunotherapy and glaucoma in the eye
Shahin Hallaj, Mohammad Mirza‐Aghazadeh‐Attari, Amin Arasteh, et al.
Life Sciences (2021) Vol. 282, pp. 119796-119796
Closed Access | Times Cited: 9
Aminopeptidase N-targeting nanomolecule-assisted delivery of VEGF siRNA to potentiate antitumour therapy by suppressing tumour revascularization and enhancing radiation response
Xue Li, Jiang Li, Chunyin Li, et al.
Journal of Materials Chemistry B (2021) Vol. 9, Iss. 36, pp. 7530-7543
Closed Access | Times Cited: 8
Functionalized drug-gene delivery materials to transport inhibitor of apoptosis protein antagonists for tumor malignancy management
Yung‐Chih Kuo, Rajendiran Rajesh
Journal of the Taiwan Institute of Chemical Engineers (2022) Vol. 133, pp. 104283-104283
Closed Access | Times Cited: 5
RETRACTED ARTICLE: Combination Cancer Immunotherapy with Dendritic Cell Vaccine and Nanoparticles Loaded with Interleukin-15 and Anti-beta-catenin siRNA Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response
Armin Mahmoud Salehi Kheshti, Farnaz Hajizadeh, Asal Barshidi, et al.
Pharmaceutical Research (2022) Vol. 39, Iss. 2, pp. 353-367
Closed Access | Times Cited: 4
Nano-medicine therapy reprogramming metabolic network of tumour microenvironment: new opportunity for cancer therapies
Xiaojie Zhang, Min An, Juntao Zhang, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 3, pp. 241-257
Closed Access
Enhancing Chemotherapy Efficacy: Investigating the Synergistic Impact of Paclitaxel and cd73 Gene Suppression on Breast Cancer Cell Proliferation and Migration
Farzaneh Hamidnia, Elif Sibel Aslan, Souzan Najafi, et al.
Cureus (2024)
Open Access
Administration of a combination of COX-2/TGF-β1 siRNAs induces hypertrophic scar fibroblast apoptosis through a TP53 mediated caspase pathway
Rao Fu, Sizheng Zhou, Chuanqi Liu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
A comprehensive review on RNA interference-mediated targeting of interleukins and its potential therapeutic implications in colon cancer
Sagari Sil, Janet Bertilla, S. Rupachandra
3 Biotech (2022) Vol. 13, Iss. 1
Closed Access | Times Cited: 1
Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model
Asal Barshidi, Vahid Karpisheh, Fatemeh Karimian Noukabadi, et al.
SSRN Electronic Journal (2021)
Closed Access
Page 1

Scroll to top